Germany· DE-A57-4caf737c3dfa7b29
Erlotinib Beta
A erlotinib product containing erlotinib, registered in Germany by Betapharm Arzneimittel Gmbh. The same ATC class is registered in 14 of our 19 countries.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
Where it is registered
Erlotinib is registered in 14 of 19 countries.
Countries holding a registration under ATC L01EB02 (erlotinib), each read from that country’s own register.
- This record: Germany, from EMA Article 57 (European Union)
- 8 of them publish a price we can compare per daily dose
Erlotinib · ATC L01EB02
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of erlotinib costs, country by country.
Normalised to the WHO defined daily dose (0.15 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Erlotinib · price per daily dose (0.15 g)
USD · FX 28 Sept 2026
- CH Switzerland$102.78
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Erlotinib
- Manufacturer
- Betapharm Arzneimittel Gmbh
- Country
- Germany (DE)
- ATC code
- L01EB02
- ATC class
- Erlotinib
- Defined daily dose
- 0.15 g, O
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
355 interactions on record for erlotinib.
Graded by severity as the source publishes them — 14 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Erlotinib · interactions on record
355 records
- 14 severe
- 192 moderate
- 2 minor
- 147 info
Most severe, free to view
- OmeprazoleA02BC01severe
- PantoprazoleA02BC02severe
- LansoprazoleA02BC03severe
- RabeprazoleA02BC04severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Erlotinib in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NetherlandsErlotinib Accordpharma 100 mg, filmomhulde tablettenAccord Healthcare B.V.
- United StatesErlotinibZydus Lifesciences Limited
- United KingdomErlotinib 100mg tabletsGlenmark Pharmaceuticals Europe Ltd
- FinlandErlotinib AvansorAvansor Pharma Oy
- FranceERLOTINIB BIOGARAN 100 mg, comprimé pelliculéBIOGARAN
- SpainERLOTINIB CIPLA 100 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFGCipla Europe
- SwedenErlotinib Avansor 100 mg Filmdragerad tablettAvansor Pharma Oy
- BelgiumErlotinib EG 100 mgEG
Authorised across Europe · EMA
The same active substance is authorised in 26 EEA countries. Names it is sold under:
- Belgium · Erlotinib Sandoz
- Bulgaria · Ерлотиниб Актавис, Ерлотиниб Крка
- Cyprus · Erlotinib Remedica
- Czechia · Erlotinib Krka, Erlotinib Teva
- Denmark · Erlotinib "stada", Erlotinib Krka
- Estonia · Erlotinib Viatris
- Spain · Erlotinib Sandoz, Erlotinib Tarbis
- Finland · Erlotinib Krka, Erlotinib Stada
- France · Erlotinib Biogaran, Erlotinib Eg
- United Kingdom (Northern Ireland) · Erlotinib Amarox, Erlotinib Glenmark
- Greece · Erlotinib Faran, Erlotinib Teva
- Croatia · Erlotinib Alpha-Medical, Erlotinib Krka
- Hungary · Erlotinib Actavis, Erlotinib Krka
- Iceland · Erlotinib Krka, Erlotinib Teva
- Italy · Erlotinib Mylan, Erlotinib Sandoz
- Liechtenstein · Tarceva
- Lithuania · Erlotinib Viatris, Varlota
- Latvia · Erlotinib Sandoz, Erlotinib Viatris
- Netherlands · Erlotinib Accordpharma, Erlotinib Amarox
- Norway · Erlotinib Krka, Tarceva
- Poland · Erlotinib Zentiva
- Portugal · Erlotinib Mylan, Erlotinib Qritou
- Romania · Erlotinib Krka, Erlotinib Viatris
- Sweden · Erlotinib Krka, Erlotinib Medical Valley
- Slovenia · Erlotinib Krka, Erlotinib Teva
- Slovakia · Erlotinib Sandoz, Erlotinib Stada
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/7b746856-379e-4a46-a616-e25573c69cf8 GET /v1/drugs/7b746856-379e-4a46-a616-e25573c69cf8?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Oral Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Erlotinib",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about erlotinib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.